P56 Real-world Treatment Patterns and Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy by Cisplatin Eligibility Status: a Us Multicenter Chart Review Study
Year: 2026
Type: conference-abstract
Source: Value in Health
Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, University of Miami, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Oregon Health & Science University, Abramson Cancer Center, University of Pennsylvania, University of California, San Francisco, University of Maryland, Baltimore
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7166106105
